Early cancer detection is an emerging frontier for healthcare companies. The ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) is among the exchange traded funds best positioned to capitalize on that trend. ARKG includes companies that merge healthcare with technology to capitalize on the...